Skip to main content
W1 female immunity
© Volker Lannert

News categories: Honors & Funding

New junior professorship for female immunity in Bonn

Anchoring gender perspectives in research: with this aim in mind, the Ministry of Culture and Science of the state of North Rhine-Westphalia is promoting gender denomination for professorships. The University of Excellence Bonn is now receiving a new junior professorship for female immunity at the Faculty of Medicine from the programme. The junior professorship is intended to expand the research focus on immunology at the University of Bonn and the University Hospital Bonn (UKB) to include important issues relating to gender and gender-specific aspects in immunology and women's health.

With the newly approved junior professorship, the already excellent research in the field of immunology at the University of Bonn will be expanded to include the strategic focus on female immunity. "Bonn is a centre for cutting-edge immunological research. Together with partners from the UKB, the German Centre for Neurodegenerative Diseases (DZNE) and the Cluster of Excellence ImmunoSensation2, the new junior professorship will link research approaches on the role of sex, gender and female health with immunology and provide new insights into immunodiversity," says Prof Bernd Weber, Dean of the Faculty of Medicine and Acting Chairman of the UKB.

Differences between men and women in the immune response have been little researched to date

Whether bacteria, viruses or fungi: our immune system recognises foreign invaders in our body and fights them. However, how the immune system reacts to intruders is different in men and women: "Women generally show stronger immune responses, which often proves beneficial in the case of infections, but they also have stronger reactions to vaccines and immunotherapies and a higher risk of autoimmune diseases," explains ImmunoSensation2 member Prof Dr Joachim Schultze from the DZNE.

Despite these initial findings on the different immune responses, women and women-specific health information, for example on menstruation, contraceptive use and menopause, are still underrepresented and under-researched in immunological research. This has negative consequences for women's health: For example, diseases that lead to different symptoms in women than in men are diagnosed later; medical therapies respond differently - or worse - in women than in men.

This is where the new Junior Professorship for Female Immunity comes in. One of its aims is to investigate how immune responses change during the menstrual cycle and menopause. In teaching, the professorship will help to raise awareness of gender-specific differences in the immune system, particularly in the "Medical Immunosciences and Infection" and "Immunobiology and Systems Immunology" degree programmes.

"It is wonderful that, thanks to the funding from the Ministry of Culture and Science, we are now able to establish a W1 professorship at the University of Bonn dedicated exclusively to immunological gender research. The professorship will make an important contribution to uncovering gender-specific differences in immune reactions and applying this knowledge clinically," says ImmunoSensation2 member Prof Dr Irmgard Förster, Vice-Rector for Equal Opportunities and Diversity, together with the Central Equal Opportunities Officer, Gabriele Alonso Rodriguez, who is delighted about the first professorship with an explicit focus on gender research in Bonn.

About the funding programme

With the aim of strengthening gender and gender studies in North Rhine-Westphalia, the Ministry of Culture and Science (MKW) is funding the establishment of gender (sub)denominations for professorships at the state universities in the state. The measure is aimed at an interdisciplinary institutional anchoring of gender perspectives, particularly in subject areas in which this perspective has so far been underdeveloped. The MWK funds the professorship for a period of three years with up to 450,000 euros; at the end of the funding period, the university undertakes to continue the respective specialisation for at least another three years after the end of the funding.

 

Contact

Prof. Dr. Irmgard Förster

Vice Rector for Equal Opportunities and Diversity
University of Bonn
Phone: +49 228 73 5886
E-mail: prorektorin.foerster@uni-bonn.de

 

Related news

News Marvin Supercomputer

News categories: Honors & Funding

Two years of the Marvin Supercomputer: Researchers in Bonn present their projects

Two years after it went into operation, the University of Bonn celebrated the Marvin Supercomputer with a community event at the Research and Technology Center for Detector Physics (FTD). Researchers from various disciplines presented projects that had been carried out using high-performance computing and used the event as an opportunity for interdisciplinary exchange. A team lead by ImmunoSensation³ members Prof. Dr. Michael Hölzel (Institute of Experimental Oncology) and PD Dr. Gregor Hagelueken (Institute of Structural Biology) use Marvin to design new proteins.
View entry
Award Ceremony, SxDiagnostics

News categories: Honors & Funding

start2grow start-up competition awards “SxDiagnostics”

The “SxDiagnostics” project from the University of Bonn and the University Hospital Bonn (UKB) prevailed against over 100 competing teams in the start2grow competition and placed in the (shared) 4th to 10th spots. Start2grow is organized nationwide by the Dortmund Economic Development Agency and celebrated its 25th anniversary this year.
View entry
Gut

News categories: Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry

Back to the news overview